Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07651553
NA

Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision

Sponsor: Sun Yat-sen University

View on ClinicalTrials.gov

Summary

TME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with potential advantages in low rectal cancer. To date, no clinical studies have directly compared the conversion and complication rates between taTME and RTME in this population. Therefore, the investigators propose to conduct a prospective, randomized, parallel-controlled clinical trial comparing taTME with RTME for low rectal cancer, aiming to provide high-level evidence for surgical decision-making and benefit more patients.

Official title: A Prospective, Randomized, Parallel-Controlled, Superiority Clinical Study Comparing Transanal Total Mesorectal Excision (taTME) and Robot-Assisted Total Mesorectal Excision (RTME) in the Treatment of Low Rectal Cancer

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

216

Start Date

2025-06-30

Completion Date

2029-04-28

Last Updated

2026-06-16

Healthy Volunteers

No

Interventions

PROCEDURE

robotic surgery vs transanal total mesorectal excsion

This study is designed to investigate the safety and superiority of transanal total mesorectal excision (taTME) in the treatment of rectal cancer compared with robot-assisted total mesorectal excision (rTME)

Locations (1)

the sixth affiliated hospital of Sun Yat-sen University

Guangzhou, Guangdong, China